The invention provides humanized immunoglobulins that bind to and neutralize γ-interferon. The antibodies are useful for treatment of diseases of the immune system, particularly autoimmune diseases.
Edits on 22 May, 2023
"Remove website redirecting to Patent Public Search front page"